ESC Professional Premium Access

Relationship of tafamidis binding site occupancy, transthyretin stabilization, and disease modification in tafamidis treated transthyretin amyloid cardiomyopathy patients

Congress Presentation

About the speaker

Doctor Tristan Maurer

Cambridge, Ma (United States of America)
0 follower

6 more presentations in this session

Diagnostic accuracy of amyloid scintigraphy for the histopathological diagnosis of cardiac transthyretin amyloidosis - a retrospective Austrian multicenter study

Speaker: Doctor N. Verheyen (Graz, AT)


The utility of splenic imaging parameters in cardiac magnetic resonance for the diagnosis of immunoglobulin light-chain amyloidosis

Speaker: Assistant Professor A. Briasoulis (Iowa City, US)


Hypertension is associated with more advanced heart failure in african americans with suspected cardiac amyloidosis

Speaker: Doctor S. Manjunath (Saint Louis, US)


Atrial fibrillation as a prognostic factor for all-cause mortality in patients with transthyretin amyloid cardiomyopathy

Speaker: Professor R. Witteles (Palo Alto, US)


Clinical characteristics, patient selection and clinical outcomes of tafamidis treatment in transthyretin amyloidosis cardiomyopathy

Speaker: Doctor S. Takashio (Kumamoto, JP)


Access the full session

Chronic heart failure - Amyloidosis

Speakers: Doctor T. Maurer, Doctor N. Verheyen, Assistant Professor A. Briasoulis, Doctor S. Manjunath, Professor R. Witteles...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb